Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Politecnico di Milano | OTHER |
Not provided
Not provided
Not provided
Parkinson's disease (PD) is a degenerative disorder characterized by a symptom triad consisting on: tremor, rigidity and bradykinesia . To these symptoms it is often added postural alteration that can stand in two different attitudes, such as the camptocormia and the syndrome of Pisa . Progressing in its evolution, PD becomes increasingly disabling, making it difficult or even impossible daily activities such as washing or dressing.The abnormal posture, with alteration of the limbs, the neck and trunk, is a recurring feature in PD, with a frequency of about 30%. Between 2% and 12.3% are more severe abnormalities such as camptocormia, the syndrome of Pisa and the anterocollis. Several studies disease plug in Neuromuscular Taping technique (NMT) among rehabilitative tools in degenerative neurological syndromes.
To the best of our knowledge, no applications were found in PD. Therefore, the current study was designed to evaluate quantitatively the effects of the NMT intervention on the trunk kinematics during standing position. More specifically, this study aims to compare the trunk kinematic variables of patients with PD who were treated with effective NMT versus those of the subjects who received only the pharmacological treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| the PD NMT Group | Active Comparator | the NMT Group were treated with NMT |
|
| The PD Group without NMT | No Intervention | The patients received only their usual pharmacological PD therapy |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neuromuscular taping | Device | NMT applications:
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) rating scale total score between baseline evaluations and end of treatment | Clinical measures were summarized as means and standard deviations for all the 46 patients. | baseline and end of treatment (1 month) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the Parkinson Disease Quality of life 8 total score between baseline evaluations and end of treatment | Clinical measures were summarized as means and standard deviations for all the 46 patients. | baseline and end of treatment (1 month) |
| Change in the Non Motor Symptoms scale total score between baseline evaluations and end of treatment |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Clinical measures were summarized as means and standard deviations for all the 46 patients. |
| baseline and end of treatment (1 month) |
| Change in the EuroQol 5 total score between baseline evaluations and end of treatment | Clinical measures were summarized as means and standard deviations for all the 46 patients. | baseline and end of treatment (1 month) |
| Change in the Freezing of Gait total score between baseline evaluations and end of treatment | Clinical measures were summarized as means and standard deviations for all the 46 patients. | baseline and end of treatment (1 month) |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |